On Tuesday during a live discussion at the High Times Business Summit, Dr. Raphael Mechoulam, known as the “Father of THC,” made an impassioned plea for good clinical trials to study the effects of medical marijuana on cancer.
A pioneer in research on the medical uses of cannabis, Mechoulam has spent four decades studying and observing the positive effects of cannabis on many of the most pressing medical conditions of our time, including Alzheimer’s disease, epilepsy, cancer and pain management.
“A huge number of people use cannabis for a variety of cancers,” Mechoulam explained to Summit attendees. “Some of them state that this is the only thing that helped them. Maybe? Maybe not. We don’t have a single, good clinical trial in cancers. Any cancers! This is a shame. But there we are.”
“We know that cannabis, or some cannabinoids are pretty good in some types of pain, but again, we don’t have good clinical trials,” he continued. “As a matter of fact, we barely have ANY clinical trials! We need clinical trials! Work in mice is fine but we have to advance.”
Mechoulam, who spoke via video conferencing, was being presented with a lifetime achievement award by High Times when he made his ardent appeal.